Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 03, 2021
Cash flows from operating activities:
Net income	$ 770,828	$ 692,379	$ 193,114
Non-cash and other reconciling items:
Depreciation	82,565	87,367	90,884
Amortization	6,048	14,959	41,033
Amortization of Operating Lease Assets	54,392	52,881	56,782
Deferred income taxes	(37,060)	(52,513)	14,650
Stock-based compensation	38,781	36,738	29,339
Impairments			15,166
Other, net	52,142	34,116	22,512
Changes in (net of effects from businesses acquired and divested):
Receivables	(461,117)	(1,132,039)	(615,353)
Inventories	(1,173,124)	(1,218,871)	(409,075)
Accounts payable	(75,943)	1,131,225	620,973
Accrued expenses and other, net	28,785	134,448	30,924
Net cash flows (used for) provided by operating activities	(713,703)	(219,310)	90,949
Cash flows from financing activities:
Issuance of notes, net of discounts	498,615	299,973	297,660
Repayment of public notes		(354,336)	(305,077)
Borrowings under accounts receivable securitization, net	258,000	274,900	22,900
Borrowings (repayments) under senior unsecured credit facility, net	728,182		(231,680)
Borrowings (repayments) under bank credit facilities and other debt, net	(96,209)	235,047	(2,789)
Repurchases of common stock	(221,730)	(184,382)
Dividends paid on common stock	(106,325)	(98,490)	(84,309)
Other, net	(5,777)	(16,653)	(10,718)
Net cash flows provided by (used for) financing activities	1,054,756	156,059	(314,013)
Cash flows from investing activities:
Purchases of property, plant and equipment	(194,674)	(48,900)	(50,363)
Acquisitions of assets and businesses			(18,381)
Proceeds from liquidation of Company Owned Life Insurance Policies		90,384
Other, net	(16,877)	9,815	7,548
Net cash flows (used for) provided by investing activities	(211,551)	51,299	(61,196)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	5,035	(34,046)	6,913
Cash and cash equivalents:
increase (decrease)	134,537	(45,998)	(277,347)
Cash and cash equivalents at beginning of year	153,693	199,691	477,038
Cash and cash equivalents at end of year	$ 288,230	$ 153,693	$ 199,691